Ignite Creation Date:
2025-12-25 @ 3:22 AM
Ignite Modification Date:
2026-03-04 @ 7:49 PM
Study NCT ID:
NCT03330405
Status:
TERMINATED
Last Update Posted:
2023-10-13
First Post:
2017-10-16
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Javelin Parp Medley: Avelumab Plus Talazoparib In Locally Advanced Or Metastatic Solid Tumors
Sponsor:
Pfizer
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Avelumab in Combination With Talazoparib Will be Investigated in Patients … | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | NSCLC, TNBC, hormone receptor positive (HR+) breast cancer, recurrent epithelial … | View |